The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

In the current study, the researchers used what is known as fragment-based drug design instead. The method involves first identifying a very small molecule that can bind to the target protein.

Presently departmental laboratories are devoted toward drug design, synthesis, and characterization. Additionally there is also a strong effort placed in protein receptor characterization and protein ...

Alongside new steps in its therapeutic pipeline—and a new push into laboratory robotics—Insilico Medicine has raised $110 ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Using a method known as “rational drug design,” Elion and Hitchings were able to successfully interfere with cell growth, giving way to a number of effective drugs for treating leukemia, gout, malaria ...

Azor is offering its innovative target selection/evaluation, novel drug design and early-stage development services to research organizations, particularly those with robust phenotypic disease ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Drug discovery has always been a complex and multi-faceted process that requires the integration of various disciplines such as biology, chemistry, and computer science. Today Artificial Intelligence ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.